Sample sent on : March 07, 2005¡@¡@¡@Report deadline :March 14, 2005
Total screening unit¡G14¡@¡@¡@¡@¡@¡@ Total reports returned¡G14
Sample No. |
A1 |
A2 |
A3 |
B1 |
B2 |
B3 |
B4 |
C1 |
C2 |
C3 |
C4 |
C5 |
D1 |
D2 |
G6PD activity* |
1 |
0.5(+)
|
0.3(+)
|
1.2(+)
|
14.0(+)
|
¡Ï |
0.38(+)
|
0.20(+)
|
0.1(+)
|
¡Ï |
¡Ï |
0.3(+)
|
0.79(+)
|
0.9(+) |
0.43(+) |
0.9(+) |
2 |
8.5
|
8.8
|
25.4
|
35.2
|
¡Ð
|
7.00
|
7.66
|
6.9
|
¡Ð
|
¡Ð
|
10.3
|
9.52
|
6.2
|
7.09
|
24.4
|
3 |
8.4
|
8.4
|
24.6
|
30.8
|
¡Ð |
7.40
|
7.66
|
6.3
|
¡Ð |
¡Ð |
10.2
|
10.09
|
6.3
|
5.47
|
24.4
|
4 |
3.4
|
3.4
|
8.8
|
25.5
|
¡Ð |
3.23
|
3.43
|
2.7
|
¡Ð |
¡Ð |
5.5
|
4.50
|
2.3(+)
|
2.28
|
6.7
|
5 |
8.5
|
8.4
|
26.0
|
27.2
|
¡Ð |
6.90
|
8.13
|
6.3
|
¡Ð |
¡Ð |
10.3
|
9.74
|
6.0 |
6.35
|
24.4 |
6 |
3.1
|
3.4
|
8.8
|
24.7
|
¡Ð
|
3.37
|
3.42
|
2.4
|
¡Ð
|
¡Ð
|
4.9
|
4.43
|
0.9(+)
|
2.02
|
6.7
|
7 |
3.1
|
3.5
|
8.9
|
24.6
|
¡Ð |
3.25
|
3.47
|
2.7
|
¡Ð |
¡Ð |
4.4(+)
|
4.67
|
2.0(+) |
2.19
|
6.7
|
8 |
0.5(+)
|
0.3(+)
|
1.0(+)
|
13.0(+)
|
¡Ï |
0.37(+)
|
0.63(+)
|
0.1(+)
|
¡Ï |
¡Ï |
0.3(+)
|
1.05(+)
|
0.1(+) |
0.33(+) |
0.9(+) |
9 |
8.1
|
8.5
|
25.2
|
29.7
|
¡Ð |
6.8
|
8.00
|
6.4
|
¡Ð |
¡Ð |
10.3
|
10.37
|
6.5
|
7.02
|
24.4
|
10 |
3.3
|
3.5
|
8.6
|
25.1
|
¡Ð |
3.4
|
3.29
|
2.6
|
¡Ð |
¡Ð |
4.9
|
4.95
|
2.4(+) |
3.28
|
6.7
|
¡@¡@* G6PD¡GU/g Hb, determined at Clin. Biochem. Res. Lab, Taipei VGH
¡@¡@ ** The positive result assigned by the participants are indicated by red color in the table.
Reagent Kit |
Laboratory |
PE (ND-1000) | A1, A2, B4,C1,D1 |
Bio-Rad | D2 |
R&D DIAGNOSTICS (OSMMR2000-D) | C5 |
R&D DIAGNOSTICS (OSMMR720) | C2 |
Gamma (G6PD-2000) | C4 |
Trinity Biotech 345UV | A3 |
Micky | B1 |
Flouro Skan | B3 |
Laboratory prepared | B2, C3 |
Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :
updated : 31 Mar, 2005